Key Takeaways
- Donald Trump proposed a $5,000 "Trump Dividend" for every U.S. adult citizen, contingent on a Republican sweep of both the House and Senate in the upcoming midterm elections.
- South Korea’s Finance Minister Koo Yun-cheol declared the nation's economic recovery "increasingly evident," with nominal GDP growing at its fastest pace in 47 years during the second quarter.
- The FDA granted accelerated approval to Bayer’s (BAYRY) sevabertinib as a first-line treatment for HER2-mutated lung cancer, significantly expanding the drug's market reach.
- Mastercard (MA) launched "Wallet Pay," a new global suite of solutions designed to enable interoperability across digital wallets for over 3.7 billion credentials.
- The KOSPI index fell 0.29% to 7,031.53 in early Thursday trading as surging oil prices, with Brent crude briefly topping $100 per barrel, fueled global inflation fears.
Political Pledges and Economic Stimulus
Former President Donald Trump has unveiled a provocative fiscal proposal dubbed the "Trump Dividend," promising a one-time $5,000 payment to every American adult. Speaking at a Republican convention in Dallas, Trump tied the payout directly to political outcomes, stating the dividend would only be issued if Republicans secure control of both the House and Senate. He likened the payment to a corporate cash distribution, claiming the U.S. economy's "tremendous strength" justifies sharing profits with "shareholders"—the citizens.
Critics and analysts have pointed to the massive scale of the proposal, which could cost an estimated $1.2 trillion based on the U.S. adult population. While Trump specified the money must be spent within the United States to stimulate domestic growth, he provided few details on the funding mechanism or legislative path for such a significant expenditure.
South Korea’s Macroeconomic Momentum
In Seoul, Finance Minister Koo Yun-cheol provided an optimistic outlook for Asia's fourth-largest economy, noting that Gross National Income (GNI) per capita is on track to exceed $40,000 this year. The minister highlighted that nominal GDP grew by 26.4% year-over-year in the second quarter, marking a historic high. Despite these gains, the government is moving to address structural issues, including plans to convert vacant industrial centers into public housing for youth and newlyweds.
However, the positive macro sentiment was tempered by immediate market pressures. The KOSPI (KOSPI) opened lower on Thursday, pressured by escalating geopolitical tensions in the Middle East that pushed energy prices higher. Large-cap tech stocks saw mixed results, with Samsung Electronics (SSNLF) sliding 0.74%, while Hyundai Motor (HYMTF) managed a modest gain of 0.52%.
Healthcare and Fintech Innovations
The pharmaceutical sector saw a major regulatory win as the U.S. FDA granted accelerated approval to Bayer’s (BAYRY) sevabertinib (marketed as Hyrnuo). The drug is now authorized as a first-line targeted therapy for adult patients with HER2-mutated non-small cell lung cancer (NSCLC). Clinical trials showed a 75% objective response rate, offering a potent new option for treatment-naive patients.
Simultaneously, Mastercard (MA) is moving to dominate the digital payment landscape with the launch of Mastercard Wallet Pay. This initiative aims to bridge the gap between various digital wallets like AlipayHK, GCash, and KakaoPay, allowing for seamless cross-border transactions. With digital wallet users projected to reach 5.2 billion globally, Mastercard’s move to provide interoperability for its 3.7 billion credentials positions the company to capture a larger share of the shifting payments ecosystem.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.